TOKYO--(BUSINESS WIRE)--Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive Officer (CEO), ...

Daiichi Sankyo Company, , an innovative global healthcare company, has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as chief executive officer (CEO), effective April 1, 2025. Dr ...

We present a reconstruction of radiation belt electron fluxes using data assimilation with low-Earth-orbiting Polar Orbiting Environmental Satellites (POES) measurements mapped to near equatorial ...

Objective: Eosinophils are hallmarks in allergic type 2 inflammation and are known to release cytotoxic granule proteins that contribute to inflammation. Eosinophils develop in the bone marrow from ...

The Rising of the Shield Hero - Season 3 [Limited Edition] (BD+DVD) 2025-02-25 (from $52.99) ...

The Dangers in My Heart - Season 1 [Collector's Edition] (Blu-ray) 2025-05-27 ...

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by ...